BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 18.04.2005

Intramammary Dosage Forms; Ceftiofur

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of ceftiofur hydrochloride suspension, by intramammary infusion, for the treatment of subclinical mastitis in dairy cattle at the time of dry off.

Source: Federal Register — Food and Drug AdministrationOpen original release →